查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
快速诊断市场：按产品、按处方、按应用、按最终用户、按地区 - 规模、份额、展望、机会分析，2023-2030 年
市场调查报告书
商品编码
1290555

快速诊断市场：按产品、按处方、按应用、按最终用户、按地区 - 规模、份额、展望、机会分析，2023-2030 年

Rapid Diagnostics Market, By Product, By Prescription, By Application, By End User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

快速诊断测试是易于使用的测试，通常会在 30 分钟内提供结果。 它是一种快速现场测试，可在 30 分钟内完成，快速准确地检测病原体的存在。 快速的结果使医疗保健专业人员/工作人员能够做出快速、明智的决策，以挽救当地患者的生命。

市场动态：

传染病/慢性病患病率不断上升、COVID-19（大流行）的爆发、护理点诊断的使用不断增加、政府的积极举措以及公众对早期诊断的认识不断增强这些是预期的关键因素在预测期内促进全球快速诊断市场的增长。

例如，2022 年 3 月，Brain Chemistry Labs 和 Arlington Scientific 合作开发了一种易于使用的快速测试套件。 该快速检测试剂盒可检测 B-甲氨基-L-丙氨酸 (BMAA) 的存在，这是蓝藻藻华中存在的一种毒素，可导致致命的麻痹性疾病肌萎缩侧索硬化症 (ALS)。这就是您所做的。

本研究的主要特点

  • 本报告对全球快速诊断市场进行了深入分析，提供了以 2022 年为基准年的预测期（2023-2030 年）的市场规模和復合年增长率。
  • 它还阐明了各个细分市场的潜在收入机会，并概述了该市场有吸引力的投资主张矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机遇、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
  • 它根据以下参数对全球快速诊断市场的主要参与者进行了介绍，包括公司亮点、产品组合、主要亮点、财务业绩和战略。
  • 本研究涵盖的主要公司包括 Abbott、Danaher、Quidel、BD、LifeScan、Siemens Healthineers、F. Hoffmann-La Roche 和 Ascensia Diabetes Care Holdings 等。
  • 从本报告中获得的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 本报告面向该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和财务分析师。
  • 利益相关者可以通过用于分析全球快速诊断市场的各种策略矩阵来促进决策。

内容：

第一章调查的目的和先决条件

  • 调查目的
  • 先决条件
  • 缩写

第二章市场展望

  • 报告摘要
    • 市场定义和范围
  • 执行摘要
  • 连贯的机会地图 (COM)

第三章市场动态、监管与趋势分析

  • 市场动态
    • 慢性病/传染病患病率上升
    • 严格的法规和快速诊断的挑战
    • Covid-19 爆发（全球大流行）
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/批准
  • PEST分析
  • 《PORTER》分析
  • 合併/收购场景

第 4 章全球快速诊断市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 关于 COVID-19 的流行病学
  • 供给侧和需求侧分析
  • 经济影响

第 5 章 2017-2030 年全球快速诊断市场（按产品）

  • 消耗品
  • 设备/分析设备

第 6 章全球快速诊断市场（按处方划分，2017-2030 年）

  • 专业诊断
  • 主页/OTC 测试

第 7 章按应用划分的全球快速诊断市场，2017-2030

  • 血糖测试
  • 心血管检查
  • 传染病检测
  • 凝血试验
  • 血液学检测
  • 癌症筛查
  • 滥用药物测试
  • 怀孕/不孕/排卵测试

第 8 章全球快速诊断市场（按最终用户划分，2017-2030 年）

  • 医院和诊所
  • 实验室
  • 个人/家庭护理环境
  • 其他

第 9 章全球快速诊断市场，按地区划分，2017-2030 年

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第 10 章竞争格局

  • Abbott
  • Danaher
  • Quidel
  • BD
  • LifeScan
  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Ascensia Diabetes Care Holdings

第 11 章部分

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5691

Rapid diagnostic tests are easy-to-use tests that provide quick results, usually 30 in minutes or less. These are quick field tests that can be performed in under 30 minutes and detect the presence of a pathogen quickly and accurately. Rapid results enable healthcare professionals/workers to make informed decisions quickly and protect the lives of their patients at the community level.

Market Dynamics:

Rise in prevalence of infectious/chronic diseases, outbreak of COVID-19 (pandemic), rise in usage of point-of-care diagnostics, favorable government initiatives, and rising awareness among people regarding early diagnosis are major factors expected to boost growth of the global rapid diagnostics market during the forecast period.

For instance, in March 2022, Brain Chemistry Labs and Arlington Scientific teamed up to develop an easy-to-use rapid test kit. The rapid test kit will detect the presence of B-methylamino-L-Alanine (BMAA), a toxin present in cyanobacterial blooms, which causes a fatal paralytic disease called Amyotrophic Lateral Sclerosis (ALS).

Key features of the study:

  • This report provides in-depth analysis of the global rapid diagnostics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global rapid diagnostics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Abbott, Danaher, Quidel, BD, LifeScan, Siemens Healthineers, F. Hoffmann-La Roche, and Ascensia Diabetes Care Holdings, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global rapid diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rapid diagnostics market.

Detailed Segmentation:

  • Global Rapid Diagnostics Market, By Product:
    • Consumables
    • Instruments/Analysers
  • Global Rapid Diagnostics Market, By Prescription:
    • Professional Diagnostics
    • At-Home/OTC-Based Testing
  • Global Rapid Diagnostics Market, By Application:
    • Blood Glucose Testing
    • Cardiometabolic Testing
    • Infectious Disease Testing
    • Blood Coagulation Testing
    • Hematology Testing
    • Cancer Testing
    • Drug of Abuse Testing
    • Pregnancy and Fertility/Ovulation Testing
  • Global Rapid Diagnostics Market, By End User:
    • Hospitals and Clinics
    • Laboratories
    • Individuals/Home Healthcare Settings
    • Others
  • By Geography:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles:
    • Abbott
    • Danaher
    • Quidel
    • BD
    • LifeScan
    • Siemens Healthineers
    • F. Hoffmann-La Roche
    • Ascensia Diabetes Care Holdings

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Prescription
    • Market Snapshot By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rise in prevalence of chronic/infectious disease
    • Stringent regulations and rapid diagnostics challenges
    • The outbreak of COVID-19 (global pandemic)
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Rapid Diagnostics Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Rapid Diagnostics Market, By Product, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Instruments/Analysers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

6. Global Rapid Diagnostics Market, By Prescription, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Professional Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • At-Home/OTC-Based Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

7. Global Rapid Diagnostics Market, By Application, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Blood Glucose Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Cardiometabolic Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Infectious Disease Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Blood Coagulation Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Hematology Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Cancer Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Drug of Abuse Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Pregnancy and Fertility/Ovulation Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

8. Global Rapid Diagnostics Market, By End User, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Individuals/Home Healthcare Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

9. Global Rapid Diagnostics Market, By Geography, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)

10. Competitive Landscape

  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quidel
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BD
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • LifeScan
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • F. Hoffmann-La Roche
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ascensia Diabetes Care Holdings
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us